0001368148-20-000030.txt : 20200401
0001368148-20-000030.hdr.sgml : 20200401
20200401180156
ACCESSION NUMBER: 0001368148-20-000030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200330
FILED AS OF DATE: 20200401
DATE AS OF CHANGE: 20200401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Campbell Laura K
CENTRAL INDEX KEY: 0001402605
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33876
FILM NUMBER: 20766729
MAIL ADDRESS:
STREET 1: 3201 CARNEGIE AVENUE
CITY: CLEVELAND
STATE: OH
ZIP: 44115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ATHERSYS, INC / NEW
CENTRAL INDEX KEY: 0001368148
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 204864095
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3201 CARNEGIE AVENUE
CITY: CLEVELAND
STATE: OH
ZIP: 44115-2634
BUSINESS PHONE: 216-431-9900
MAIL ADDRESS:
STREET 1: 3201 CARNEGIE AVENUE
CITY: CLEVELAND
STATE: OH
ZIP: 44115-2634
FORMER COMPANY:
FORMER CONFORMED NAME: BTHC VI Inc
DATE OF NAME CHANGE: 20060629
4
1
wf-form4_158577849369298.xml
FORM 4
X0306
4
2020-03-30
0
0001368148
ATHERSYS, INC / NEW
ATHX
0001402605
Campbell Laura K
3201 CARNEGIE AVENUE
CLEVELAND
OH
44115-2634
0
1
0
0
Senior Vice Pres Finance
Common Stock
2020-03-30
4
S
0
44929
2.4001
D
561005
D
Common Stock
2020-03-31
4
S
0
51483
2.9011
D
509522
D
Common Stock
2020-04-01
4
S
0
47339
3.4035
D
462183
D
Common Stock
2020-04-01
4
S
0
47474
3.8111
D
414709
D
Common Stock
2020-04-01
4
S
0
43081
4.2559
D
371628
D
Shares sold pursuant to a predefined Rule 10b5-1 trading plan that commenced in July 2018. A predefined number of shares may be sold from time-to-time based on predefined price increases over a two-year period.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $2.405, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.90 to $2.909, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.40 to $3.44, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.80 to $3.84, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.25 to $4.285, inclusive.
Securities beneficially owned are comprised of (1) 250,072 shares of common stock owned and (2) unvested restricted stock units aggregating 121,556 related to annual awards, which vest quarterly over a three or four-year period from date of grant.
/s/ Laura K. Campbell
2020-04-01